These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27612996)

  • 1. HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.
    Kopecky C; Ebtehaj S; Genser B; Drechsler C; Krane V; Antlanger M; Kovarik JJ; Kaltenecker CC; Parvizi M; Wanner C; Weichhart T; Säemann MD; Tietge UJ
    J Am Soc Nephrol; 2017 Mar; 28(3):769-775. PubMed ID: 27612996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.
    Annema W; Dikkers A; de Boer JF; Dullaart RP; Sanders JS; Bakker SJ; Tietge UJ
    J Am Soc Nephrol; 2016 Feb; 27(2):595-603. PubMed ID: 26319244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.
    Silbernagel G; Genser B; Drechsler C; Scharnagl H; Grammer TB; Stojakovic T; Krane V; Ritz E; Wanner C; März W
    J Am Soc Nephrol; 2015 Feb; 26(2):484-92. PubMed ID: 25012163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
    Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
    Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study.
    Liu C; Zhang Y; Ding D; Li X; Yang Y; Li Q; Zheng Y; Wang D; Ling W
    Atherosclerosis; 2016 Jun; 249():116-24. PubMed ID: 27088866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.
    Untersteller K; Meissl S; Trieb M; Emrich IE; Zawada AM; Holzer M; Knuplez E; Fliser D; Heine GH; Marsche G
    J Lipid Res; 2018 Jul; 59(7):1256-1265. PubMed ID: 29789355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
    Pfau A; Ermer T; Coca SG; Tio MC; Genser B; Reichel M; Finkelstein FO; März W; Wanner C; Waikar SS; Eckardt KU; Aronson PS; Drechsler C; Knauf F
    J Am Soc Nephrol; 2021 Sep; 32(9):2375-2385. PubMed ID: 34281958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
    Fellström BC; Jardine AG; Schmieder RE; Holdaas H; Bannister K; Beutler J; Chae DW; Chevaile A; Cobbe SM; Grönhagen-Riska C; De Lima JJ; Lins R; Mayer G; McMahon AW; Parving HH; Remuzzi G; Samuelsson O; Sonkodi S; Sci D; Süleymanlar G; Tsakiris D; Tesar V; Todorov V; Wiecek A; Wüthrich RP; Gottlow M; Johnsson E; Zannad F;
    N Engl J Med; 2009 Apr; 360(14):1395-407. PubMed ID: 19332456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Predictive Role of Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio According to Renal Function in Patients with Acute Myocardial Infarction.
    Kim JS; Kim W; Woo JS; Lee TW; Ihm CG; Kim YG; Moon JY; Lee SH; Jeong MH; Jeong KH;
    PLoS One; 2016; 11(10):e0165484. PubMed ID: 27788233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis.
    Yamamoto S; Narita I; Kotani K
    Clin Chim Acta; 2016 Jun; 457():117-22. PubMed ID: 27087419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia.
    Tschöpe W; Koch M; Thomas B; Ritz E
    Nephron; 1993; 64(3):354-8. PubMed ID: 8341379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
    Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
    Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.